Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Prevalence of Xenotropic Murine Leukemia Virus-Related Virus Infection in Different Risk Populations in Spain.
Arredondo M, Hackett J Jr, Bethencourt FR, Treviño A, Escudero D, Collado A, Qiu X, Swanson P, Soriano V, Mendoza CD.
AIDS Res Hum Retroviruses. 2012 Feb 21. [Epub ahead of print]
Related citations
Efficacy and Safety Outcomes Among Treatment-Experienced Women and Men Treated with Etravirine in GRACE (Gender, Race And Clinical Experience).
Hodder S, Jayaweera D, Mrus J, Ryan R, Witek On Behalf Of The Grace Study Group J.
AIDS Res Hum Retroviruses. 2012 Apr 2. [Epub ahead of print]
Workshop Summary: Novel Biomarkers for HIV Incidence Assay Development.
Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, Keele B, Shapiro S, McMichael A, Burns DN.
AIDS Res Hum Retroviruses. 2012 Feb 24. [Epub ahead of print]
Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Subtype C Env gp120 Sequences Among Four Drug-Naive Families Following Subsequent Heterosexual and Vertical Transmissions.
Duri K, Gumbo F, Kristiansen K, Mapingure M, Munjoma M, Chirenje M, Rusakaniko S, Stray-Pedersen B, Műller F.
AIDS Res Hum Retroviruses. 2012 Mar 2. [Epub ahead of print]
Half the 14 million people in poorer countries who need antiretrovirals get them.
Gulland A.
BMJ. 2011 Nov 22;343:d7576. doi: 10.1136/bmj.d7576. No abstract available.
Antiretroviral therapy programmes in resource limited settings.
del Rio C, Armstrong W.
BMJ. 2011 Nov 9;343:d6853. doi: 10.1136/bmj.d6853. No abstract available.
Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis.
Click ES, Moonan PK, Winston CA, Cowan LS, Oeltmann JE.
Clin Infect Dis. 2012 Jan 15;54(2):211-9.
High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
Harris JR, Lindsley MD, Henchaichon S, Poonwan N, Naorat S, Prapasiri P, Chantra S, Ruamcharoen F, Chang LS, Chittaganpitch M, Mehta N, Peruski L, Maloney SA, Park BJ, Baggett HC.
Clin Infect Dis. 2012 Mar 1;54(5):e43-50. Epub 2011 Dec 23.
Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.
Goetghebuer T, Le Chenadec J, Haelterman E, Galli L, Dollfus C, Thorne C, Judd A, Keiser O, Ramos JT, Levy J, Warszawski J; European Infant Collaboration Group.
Clin Infect Dis. 2012 Mar;54(6):878-81. Epub 2011 Dec 23.
The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS.
Duracinsky M, Herrmann S, Berzins B, Armstrong AR, Kohli R, Le Coeur S, Diouf A, Fournier I, Schechter M, Chassany O.
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):498-505.
Uptake and outcome of combination antiretroviral therapy in men who have sex with men according to ethnic group: the UK CHIC Study.
United Kingdom Collaborative HIV Cohort Study Group.
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):523-9.
Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors.
Alam N, Cortina-Borja M, Goetghebuer T, Marczynska M, Vigano A, Thorne C; European Paediatric HIV and Lipodystrophy Study Group in EuroCoord.
J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):314-24.
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.
Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ.
J Clin Invest. 2012 Jan 3;122(1):359-67. doi: 10.1172/JCI60202. Epub 2011 Dec 27.
Rare serotype adenoviral vectors for HIV vaccine development.
Michael NL.
J Clin Invest. 2012 Jan 3;122(1):25-7. doi: 10.1172/JCI60988. Epub 2011 Dec 27.
Detection of acute HIV infection: we can't close the window.
Branson BM, Stekler JD.
J Infect Dis. 2012 Feb;205(4):521-4. Epub 2011 Dec 29. No abstract available.
Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
Rosenberg NE, Kamanga G, Phiri S, Nsona D, Pettifor A, Rutstein SE, Kamwendo D, Hoffman IF, Keating M, Brown LB, Ndalama B, Fiscus SA, Congdon S, Cohen MS, Miller WC.
J Infect Dis. 2012 Feb;205(4):528-34. Epub 2011 Dec 29.
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
Lewis J, Walker AS, Castro H, De Rossi A, Gibb DM, Giaquinto C, Klein N, Callard R.
J Infect Dis. 2012 Feb;205(4):548-56. Epub 2011 Dec 28.
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.
Canducci F, Ceresola ER, Boeri E, Spagnuolo V, Cossarini F, Castagna A, Lazzarin A, Clementi M.
J Infect Dis. 2011 Dec;204(11):1811-5. Epub 2011 Oct 7.
Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes.
Chiang K, Sung TL, Rice AP.
J Virol. 2012 Mar;86(6):3244-52. Epub 2011 Dec 28.
Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors.
Hultquist JF, Binka M, LaRue RS, Simon V, Harris RS.
J Virol. 2012 Mar;86(5):2874-7. Epub 2011 Dec 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on